Evidence map›Paper›PMID 26106140›Full record

ReviewCarcinogenesis2015

Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?

R Brooks Robey, Judith Weisz, Nancy B Kuemmerle, Anna C Salzberg, Arthur Berg, Dustin G Brown, Laura Kubik, Roberta Palorini, Fahd Al-Mulla, Rabeah Al-Temaimi and 20 more

Abstract readReview
In one paragraph

Review in Carcinogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

R Brooks RobeyResearch and Development Service, Veterans Affairs Medical Center, White River Junction, VT 05009, USA, Departments of Medicine and of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH 03756, USA, R.Brooks.Robey@Dartmouth.edu.
Judith WeiszDepartments of Gynecology and Pathology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Nancy B KuemmerleResearch and Development Service, Veterans Affairs Medical Center, White River Junction, VT 05009, USA, Departments of Medicine and of.
Anna C SalzbergDepartments of Gynecology and Pathology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Arthur BergDepartments of Gynecology and Pathology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Dustin G BrownDepartment of Environmental and Radiological Health Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523, USA.
Laura KubikNicholas School of the Environment, Duke University, Durham, NC 27708, USA.
Roberta PaloriniDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, 20126, Italy, SYSBIO Center for Systems Biology, Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan 20126, Italy.
Fahd Al-MullaDepartment of Pathology, Kuwait University, Safat 13110, Kuwait.
Rabeah Al-TemaimiDepartment of Pathology, Kuwait University, Safat 13110, Kuwait.
Annamaria ColacciCenter for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna, 40126, Italy.
Chiara MondelloInstitute of Molecular Genetics, National Research Council, Pavia 27100, Italy.
Jayadev RajuToxicology Research Division, Bureau of Chemical Safety Food Directorate, Health Products and Food Branch Health Canada, Ottawa, Ontario K1A0K9, Canada.
Jordan WoodrickMolecular Oncology Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, 20057 USA.
A Ivana ScovassiInstitute of Molecular Genetics, National Research Council, Pavia 27100, Italy.
Neetu SinghAdvanced Molecular Science Research Centre, King George's Medical University, Lucknow Uttar Pradesh 226003, India.
Monica VaccariCenter for Environmental Carcinogenesis and Risk Assessment, Environmental Protection and Health Prevention Agency, Bologna, 40126, Italy.
Rabindra RoyMolecular Oncology Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, 20057 USA.
Stefano ForteMediterranean Institute of Oncology, Viagrande 95029, Italy.
Lorenzo MemeoMediterranean Institute of Oncology, Viagrande 95029, Italy.
Hosni K SalemUrology Department, kasr Al-Ainy School of Medicine, Cairo University, El Manial, Cairo, 12515, Egypt.
Amedeo AmedeiDepartment of Experimental and Clinical Medicine, University of Firenze, Firenze, 50134, Italy.
Roslida A HamidFaculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia.
Graeme P WilliamsDepartment of Molecular Medicine, University of Reading, Reading RG6 6UB, UK.
Leroy LoweCentre for Biophotonics, LEC, Lancaster University, Bailrigg, Lancaster LA1 4YQ, UK, Getting to Know Cancer, Truro, Nova Scotia B2N 1X5, Canada, and.
Joel MeyerNicholas School of the Environment, Duke University, Durham, NC 27708, USA.
Francis L MartinCentre for Biophotonics, LEC, Lancaster University, Bailrigg, Lancaster LA1 4YQ, UK.
William H BissonEnvironmental and Molecular Toxicology, Environmental Health Science Center, Oregon State University, Corvallis, OR 97331, USA.
Ferdinando ChiaradonnaDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, 20126, Italy, SYSBIO Center for Systems Biology, Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan 20126, Italy.
Elizabeth P RyanDepartment of Environmental and Radiological Health Sciences, Colorado State University/Colorado School of Public Health, Fort Collins, CO 80523, USA.

Funding

Zebrafish as a Detector of Organophosphate ExposureP42ES010356 · NIEHS · DUKE UNIVERSITY · PI EDWARD D LEVIN · 2000 to 2026
$56.2M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Regulations of DNA Alkylation/Deamination Damage RepairR01CA092306 · NCI · INSTITUTE FOR CANCER PREVENTION · PI ROY, RABINDRA · 2003 to 2013
$2.8M
The Role of Mitochondrial DNA Damage in NeurodegenerationR01ES017540 · NIEHS · DUKE UNIVERSITY · PI MEYER, JOEL NEWMAN · 2011 to 2015
$1.8M
DNA Repair of Endogenous Lesions in CarcinogenesisR01CA113447 · NCI · GEORGETOWN UNIVERSITY · PI ROY, RABINDRA · 2006 to 2010
$1.4M
The Halifax Project: Chemical Mixtures and CancerR13ES023276 · NIEHS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI CARPENTER, DAVID ORLO · 2013 to 2013
$25k
NCI NIH HHS CA113447NCI NIH HHS CA92306NCI NIH HHS CA92306-S1NCI NIH HHS R01 CA092306NCI NIH HHS R01 CA113447NCI NIH HHS T32 CA009686NIEHS NIH HHS ES010356NIEHS NIH HHS P42 ES010356NIEHS NIH HHS R01 ES017540NIEHS NIH HHS R13 ES023276
6 · The paper itself

Abstract

Environmental contributions to cancer development are widely accepted, but only a fraction of all pertinent exposures have probably been identified. Traditional toxicological approaches to the problem have largely focused on the effects of individual agents at singular endpoints. As such, they have incompletely addressed both the pro-carcinogenic contributions of environmentally relevant low-dose chemical mixtures and the fact that exposures can influence multiple cancer-associated endpoints over varying timescales. Of these endpoints, dysregulated metabolism is one of the most common and recognizable features of cancer, but its specific roles in exposure-associated cancer development remain poorly understood. Most studies have focused on discrete aspects of cancer metabolism and have incompletely considered both its dynamic integrated nature and the complex controlling influences of substrate availability, external trophic signals and environmental conditions. Emerging high throughput approaches to environmental risk assessment also do not directly address the metabolic causes or consequences of changes in gene expression. As such, there is a compelling need to establish common or complementary frameworks for further exploration that experimentally and conceptually consider the gestalt of cancer metabolism and its causal relationships to both carcinogenesis and the development of other cancer hallmarks. A literature review to identify environmentally relevant exposures unambiguously linked to both cancer development and dysregulated metabolism suggests major gaps in our understanding of exposure-associated carcinogenesis and metabolic reprogramming. Although limited evidence exists to support primary causal roles for metabolism in carcinogenesis, the universality of altered cancer metabolism underscores its fundamental biological importance, and multiple pleiomorphic, even dichotomous, roles for metabolism in promoting, antagonizing or otherwise enabling the development and selection of cancer are suggested.

Indexed as

AnimalsCarcinogenesisCarcinogens, EnvironmentalEnvironmental ExposureHumansNeoplasmsCarcinogens, Environmental

Identifiers

PMID26106140
PMCPMC4565609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.